Marvin Martens, MSc (M.T.L.J.)
Martens, M. T. L. J. (2024). Adverse outcome pathways coming to life: exploring new ways to support risk assessments. [Doctoral Thesis, Maastricht University]. Maastricht University. https://doi.org/10.26481/dis.20240129mm
More information about this publication
Martens, M., Verbruggen, T., Nymark, P., Grafstrom, R., Burgoon, L. D., Aladjov, H., Andon, F. T., Evelo, C. T., & Willighagen, E. L. (2018). Introducing WikiPathways as a Data-Source to Support Adverse Outcome Pathways for Regulatory Risk Assessment of Chemicals and Nanomaterials. Frontiers in Genetics, 9, Article 661. https://doi.org/10.3389/fgene.2018.00661
More information about this publication
Martens, M., Ammar, A., Riutta, A., Waagmeester, A., Slenter, D., Hanspers, K., Miller, R., Digles, D., Lopes, E. N., Ehrhart, F., Dupuis, L. J., Winckers, L. A., Coort, S. L., Willighagen, E. L., Evelo, C. T., Pico, A. R., & Kutmon, M. (2021). WikiPathways: connecting communities. Nucleic Acids Research, 49(D1), D613-D621. https://doi.org/10.1093/nar/gkaa1024
More information about this publication
Martens, M., Evelo, C. T., & Willighagen, E. L. (2022). Providing Adverse Outcome Pathways from the AOP-Wiki in a Semantic Web Format to Increase Usability and Accessibility of the Content. Applied in Vitro Toxicology, 8(1), 2-13. https://doi.org/10.1089/aivt.2021.0010
More information about this publication
Mortensen, H. M., Martens, M., Senn, J., Levey, T., Evelo, C. T., Willighagen, E. L., & Exner, T. (2022). The AOP-DB RDF: Applying FAIR Principles to the Semantic Integration of AOP Data Using the Research Description Framework. Frontiers in Toxicology, 4. https://doi.org/10.3389/ftox.2022.803983
More information about this publication
Murugadoss, S., Vrcek, I. V., Pem, B., Jagiello, K., Judzinska, B., Sosnowska, A., Martens, M., Willighagen, E. L., Puzyn, T., Dusinska, M., Cimpan, M. R., Fessard, V., & Hoet, P. H. (2021). A Strategy Towards the Generation of Testable Adverse Outcome Pathways for Nanomaterials. Altex-Alternatives To Animal Experimentation, 38(4), 580-594. https://doi.org/10.14573/altex.2102191
More information about this publication
Kyzer, J. L., & Martens, M. (2021). Metabolism and Toxicity of Fluorine Compounds. Chemical Research in Toxicology, 34(3), 678-680. https://doi.org/10.1021/acs.chemrestox.0c00439
More information about this publication
Martens, M., Stierum, R., Schymanski, E. L., Evelo, C. T., Aalizadeh, R., Aladjov, H., Arturi, K., Audouze, K., Babica, P., Berka, K., Bessems, J., Blaha, L., Bolton, E. E., Cases, M., Damalas, D. ., Dave, K., Dilger, M., Exner, T., Geerke, D. P., ... Et al. (2023). ELIXIR and Toxicology: a community in development. F1000Research, 10(1), Article 1129. https://doi.org/10.12688/f1000research.74502.2
More information about this publication
Murugadoss, S., Vinkovic Vrcek, I., Schaffert, A., Paparella, M., Pem, B., Sosnowska, A., Stepnik, M., Martens, M., Willighagen, E. L., Puzyn, T., Roxana Cimpan, M., Lemaire, F., Mertens, B., Dusinska, M., Fessard, V., & Hoet, P. H. (2024). Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals. ALTEX, 41(1), 76-90. https://doi.org/10.14573/altex.2305011
More information about this publication
Anfray, C., Mainini, F., Digifico, E., Maeda, A., Sironi, M., Erreni, M., Anselmo, A., Ummarino, A., Gandoy, S., Exposito, F., Redrado, M., Serrano, D., Calvo, A., Martens, M., Bravo, S., Mantovani, A., Allavena, P., & Andon, F. T. (2021). Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity. Journal for ImmunoTherapy of Cancer, 9(9), Article e002408. https://doi.org/10.1136/jitc-2021-002408
More information about this publication
![](/sites/default/files/ppp/70055468/Profile_MM_2023.png)
Marvin Martens, MSc (M.T.L.J.)
Researcher
Bioinformatica
School of Nutr and Transl Res in Metab
Fac. Health, Medicine and Life Sciences